Maine Doctor Loses DEA Registration for Controlled Substances
Published Date: 7/14/2026
Notice
Summary
Dr. Shane Lydon's license to handle controlled substances in Maine has been revoked because he lost his state authority and didn’t ask for a hearing. This means he can no longer prescribe or manage these drugs, effective immediately. Anyone relying on his registration should update their records and note this change to avoid legal trouble.
Analyzed Economic Effects
3 provisions identified: 0 benefits, 3 costs, 0 mixed.
DEA Registration Revoked for Dr. Lydon
DEA Certificate of Registration No. FL1479220 issued to Shane Lydon, M.D. is revoked because his Maine medical license expired on June 30, 2025. As a result, Dr. Lydon is not authorized to prescribe, dispense, or otherwise handle controlled substances in Maine; the Order is effective August 13, 2026.
Pending Renewal/Additional Registration Denied
The Order denies any pending applications by Shane Lydon, M.D. to renew or modify Certificate of Registration No. FL1479220 and denies any other pending application by him for additional DEA registration in Maine. This denial takes effect August 13, 2026.
Those Relying on His Registration Must Update Records
Entities or individuals relying on Shane Lydon, M.D.'s DEA registration should update their records to reflect the revocation and denial of pending applications effective August 13, 2026, to avoid potential legal or compliance issues.
Your PRIA Score
Personalized for You
How does this regulation affect your finances?
Sign up for a PRIA Policy Scan to see your personalized alignment score for this federal register document and every other regulation we track. We analyze your financial profile against policy provisions to show you exactly what matters to your wallet.
Key Dates
Department and Agencies
Related Federal Register Documents
2026-11526 — Implementation of the Substance Use-Disorder Prevention That Promotes Opioid Recovery and Treatment for Patients and Communities Act of 2018: Dispensing and Administering Controlled Substances for Medication-Assisted Treatment
Starting July 9, 2026, new rules make it easier for doctors and pharmacies to provide medicine that helps people recover from opioid addiction. These changes affect healthcare providers by expanding who can give medication-assisted treatment and how pharmacies can deliver these medicines. The goal? Faster, safer access to treatment with clear rules that save time and support recovery.
2026-10128 — Revision of Applications for Manufacturing and Procurement Quotas
The DEA wants to update how companies apply for permission to make and buy certain controlled drugs and chemicals. These changes will make the rules clearer, help prevent drug shortages, and ensure enough supply for medical and scientific needs. If you’re a manufacturer or involved in this process, get ready to follow new steps and share your thoughts by July 20, 2026.
2026-14136 — Barlow St-Clair Lynch, M.D.; Decision and Order
Dr. Barlow St-Clair Lynch from Maine lost his DEA registration because he no longer has the legal right to handle controlled substances in his state. He didn’t ask for a hearing, so the DEA moved forward and officially revoked his registration. This means he can’t prescribe or manage controlled drugs anymore, effective immediately, impacting his medical practice and any related income.
2026-14135 — David Enright, M.D.; Decision and Order
Dr. David Enright from Maine lost his DEA registration because he no longer has the legal right to handle controlled substances in his state. He didn’t ask for a hearing, so the DEA moved forward and officially revoked his registration. This means he can’t prescribe or manage controlled drugs anymore, effective immediately.
2026-13988 — Frederick Tanzer, M.D.; Decision and Order
Dr. Frederick Tanzer from Ohio lost his DEA registration because he no longer has permission to handle controlled substances in his state. He didn’t ask for a hearing, so the DEA moved forward and officially revoked his registration. This means Dr. Tanzer can’t legally prescribe or handle certain drugs anymore, effective immediately.
2026-13992 — Timothy Genetta, D.O.; Decision and Order
Dr. Timothy Genetta from Ohio lost his DEA registration because he no longer has the legal right to handle controlled substances in his state. He didn’t ask for a hearing, so the DEA canceled his registration by default. This means he must stop prescribing or handling these drugs immediately, with no money or timing benefits for him.
Previous / Next Documents
Previous: 2026-14136 — Barlow St-Clair Lynch, M.D.; Decision and Order
Dr. Barlow St-Clair Lynch from Maine lost his DEA registration because he no longer has the legal right to handle controlled substances in his state. He didn’t ask for a hearing, so the DEA moved forward and officially revoked his registration. This means he can’t prescribe or manage controlled drugs anymore, effective immediately, impacting his medical practice and any related income.
Next: 2026-14138 — Common Alloy Aluminum Sheet From India: Preliminary Results and Rescission, in Part, of Countervailing Duty Administrative Review; 2024
The U.S. Department of Commerce found that some Indian aluminum sheet makers got unfair government help during 2024, so they’re reviewing extra taxes on those imports. However, three companies are off the hook because the review for them was canceled. This update starts July 14, 2026, and could affect prices and trade for U.S. aluminum businesses.